Rare diseases
Investigational molecules
Locations
Long-Term Study of Imeroprubart in Adults With Graves' Disease
PolandBMN 333 Versus Vosoritide in Children With Achondroplasia
PolandAZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma
PolandA study to evaluate the safety and effectiveness of MB-001 in adults with moderate to severe ulcerative colitis
PolandA study to evaluate the efficacy and safety of rilzabrutinib in adults with active IgG4-related disease
PolandComparing RO7771950 with a drug combination of tucatinib, trastuzumab, and capecitabine in patients with HER2-positive metastatic or locally advanced breast cancer
PolandA study to evaluate the effectiveness and safety of clemizole hydrochloride as an additional treatment for patients with Lennox-Gastaut syndrome
PolandA study of pumitamig and ipilimumab in patients with advanced or unresectable liver cancer
PolandA study to evaluate the effectiveness and safety of AZD1163 in adults with moderate to severe rheumatoid arthritis
PolandA study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia
PolandA study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis
PolandA Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
